These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa. Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173 [TBL] [Abstract][Full Text] [Related]
8. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215 [TBL] [Abstract][Full Text] [Related]
9. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635 [TBL] [Abstract][Full Text] [Related]
10. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333 [TBL] [Abstract][Full Text] [Related]
11. Extrusion of penem antibiotics by multicomponent efflux systems MexAB-OprM, MexCD-OprJ, and MexXY-OprM of Pseudomonas aeruginosa. Okamoto K; Gotoh N; Nishino T Antimicrob Agents Chemother; 2002 Aug; 46(8):2696-9. PubMed ID: 12121960 [TBL] [Abstract][Full Text] [Related]
12. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Hocquet D; Nordmann P; El Garch F; Cabanne L; Plésiat P Antimicrob Agents Chemother; 2006 Apr; 50(4):1347-51. PubMed ID: 16569851 [TBL] [Abstract][Full Text] [Related]
13. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825 [TBL] [Abstract][Full Text] [Related]
14. The substrate specificity of tripartite efflux systems of Pseudomonas aeruginosa is determined by the RND component. Murata T; Kuwagaki M; Shin T; Gotoh N; Nishino T Biochem Biophys Res Commun; 2002 Nov; 299(2):247-51. PubMed ID: 12437977 [TBL] [Abstract][Full Text] [Related]
15. MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. Hocquet D; Vogne C; El Garch F; Vejux A; Gotoh N; Lee A; Lomovskaya O; Plésiat P Antimicrob Agents Chemother; 2003 Apr; 47(4):1371-5. PubMed ID: 12654672 [TBL] [Abstract][Full Text] [Related]
16. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Aires JR; Köhler T; Nikaido H; Plésiat P Antimicrob Agents Chemother; 1999 Nov; 43(11):2624-8. PubMed ID: 10543738 [TBL] [Abstract][Full Text] [Related]
17. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system. Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743 [TBL] [Abstract][Full Text] [Related]
18. Knock-out of multidrug efflux pump MexXY-OprM results in increased susceptibility to antimicrobial peptides in Pseudomonas aeruginosa. Neidig A; Strempel N; Waeber NB; Nizer WSDC; Overhage J Microbiol Immunol; 2023 Sep; 67(9):422-427. PubMed ID: 37424105 [TBL] [Abstract][Full Text] [Related]
19. MexXY RND pump of Singh M; Sykes EME; Li Y; Kumar A Microbiology (Reading); 2020 Nov; 166(11):1095-1106. PubMed ID: 32909933 [TBL] [Abstract][Full Text] [Related]
20. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin. Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417 [No Abstract] [Full Text] [Related] [Next] [New Search]